Clinical activity

The Sannio Tech consortium conducts clinical studies on the efficacy and safety of the treatment of various food supplements. The clinical studies carried out within the consortium have the primary objective of establishing the healthy efficacy of the supplement, documenting the biochemical mechanisms that can be correlated to it and the absence of toxicity in normal conditions of exposure. In addition to accumulating scientific evidence to promote a specific benefit or therapeutic indications of a given food supplement, the conduction of clinical trials within the consortium takes into account the general principles of the rules of good clinical practice (GCP).

The accredited National Health Service laboratory provides the following analysis services:

  • basic clinical chemical analysis;
  • specialized analyses;
  • microbiological and parasitological analyses;
  • genetic analysis;
  • lipidomic analysis;
  • mineralgrams;
  • food intolerance;
  • intestinal dysbiosis tests;
  • pharmacogenomics testing.


  • Genetic tests available: KRAS Mutated in 35-45% of CRCs, renders anti-EGFR therapy ineffective. Detectable mutations: codon 12, codon 61.
  • BRAF Mutated in 15-25% of CRCs, renders anti-EGFR therapy ineffective. Detectable mutations: V600E.
  • Dihydropyrimidine dehydrogenase (DPD) deficiency, associated with 5-FU toxicity. Detectable mutations: Loss of the exon 14.
  • Person Gene. Customize your drug therapy based on your genes.


Dietary imbalances, drug abuse, stress, smoking and pollution can all create excessive deficiencies or accumulations of minerals that can cause innumerable disorders. To implement therapeutic strategies, in order to improve our health, it is possible to perform mineralograms, or mineral tissue analysis of hair, which permits evaluating the levels of minerals essential for our health and the main toxic minerals contained in our cells.


Intestinal dysbiosis is an alteration of intestinal enzymes and bacterial flora. This imbalance can lead to swelling, constipation, diarrhea, reduced strength, general discomfort, mood swings, and sleep disorders. It is possible to evaluate intestinal dysbiosis via detectable biomarkers in urine, which permits highlighting the excess or absence of products derived from the metabolic activities of intestinal bacterial flora.


Lipidomic analysis permits an examination of the fatty acid composition of our organism in order to guide food choices in a personalized way, rebalancing any excesses or shortcomings:
  • in overweight people
  • for the health of our heart
  • in pregnant women
  • in sport, to improve athletic performance
  • for the health of our brain and sight
  • in subjects prone to mood swings

CONSORZIO SANNIO TECH  Sede Operativa: S.S. Appia km 7- Zona Pip
82030  APOLLOSA (BN)  P.IVA: 01352970626
tel +39 0824 1810689 fax +39 0824 364660

Sede Legale Via C. Beccaria, 28  82100  BENEVENTO

Iscritto alla Camera di Commercio di Benevento nella Sezione Speciale in qualita' di

02Il Marchio Europeo di Qualità EQN certifica la qualità dei principi attivi funzionali delle preparazioni nutraceutiche.



©2018 Sannio Tech - Branding by  Powered by A. D. Engineering Technology System